2023
DOI: 10.3390/cancers15102701
|View full text |Cite
|
Sign up to set email alerts
|

COL7A1 Expression Improves Prognosis Prediction for Patients with Clear Cell Renal Cell Carcinoma Atop of Stage

Abstract: Clear-cell renal cell carcinoma (ccRCC) accounts for 75% of kidney cancers. Due to the high recurrence rate and treatment options that come with high costs and potential side effects, a correct prognosis of patient survival is essential for the successful and effective treatment of patients. Novel biomarkers could play an important role in the assessment of the overall survival of patients. COL7A1 encodes for collagen type VII, a constituent of the basal membrane. COL7A1 is associated with survival in many can… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 50 publications
0
2
0
Order By: Relevance
“…26 The in vitro knockdown of COL7A1 expression significantly affected ccRCC cell migration. 27 SPTBN1 abrogates renal clear-cell carcinoma progression via glycolytic reprogramming in a GPT2dependent manner. 28 ASGR1 could regulate the differentiation of monocytes into macrophages through the NF-κB/ ATF5 pathway, thus promoting liver injury in patients with sepsis.…”
Section: Discussionmentioning
confidence: 98%
“…26 The in vitro knockdown of COL7A1 expression significantly affected ccRCC cell migration. 27 SPTBN1 abrogates renal clear-cell carcinoma progression via glycolytic reprogramming in a GPT2dependent manner. 28 ASGR1 could regulate the differentiation of monocytes into macrophages through the NF-κB/ ATF5 pathway, thus promoting liver injury in patients with sepsis.…”
Section: Discussionmentioning
confidence: 98%
“…The results showed that the model risk score was significantly related to prognosis, indicated that the imbalanced expression of BMRGs may play different biological roles in the tumorigenesis, progression and tumor microenvironment in BLCA. Studies have shown that high COL7A1 expression is associated with poor prognosis in clear cell renal cell carcinoma (ccRCC), and in vitro knockdown of COL7A1 expression significantly affects the migratory ability of ccRCC cells [ 25 ]. Other studies have also shown that FBN2, CSPG4 and UNC5C as oncogenes were significantly associated with poor prognosis, which is in line with our findings [ 26 28 ].…”
Section: Discussionmentioning
confidence: 99%